Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) advancement o...

Daiichi pays for Merck $170M to create lung cancer cells T-cell engager treaty

.Merck &amp Co. has actually swiftly recovered a few of the expenses of its own Harp on Therapeutics...

BioMarin standstills preclinical genetics treatment for heart condition

.After BioMarin carried out a spring well-maintained of its pipe in April, the company has actually ...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks handle

.Large Pharmas remain stuck to the idea of molecular adhesive degraders. The most recent company to ...

Life scientific research credit score agency introduces with $600M

.A new worldwide life science credit rating organization, called Symbiotic Capital, has actually inc...

BMS trenches TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more large bet coming from the Caforio era, ending a pac...

Nuvation halts wager inhibitor after considering stage 1 data

.After looking at phase 1 data, Nuvation Biography has determined to stop work with its own single t...

' Scientific instinct' led FDA advisors to support Zevra's uncommon disease med

.Zevra Rehabs' rare ailment medicine seems to become on the pathway to confirmation this autumn afte...

Pfizer takes $230M attacked after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has blown a $230 mil...

AC Immune views 'spots' prospective in Alzheimer's medication information

.After much more than two decades of focus on neurodegenerative conditions, Swiss biotech a/c Invuln...